Related Experiment Video
Updated: May 8, 2026
07:12
Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
Do giant parathyroid adenomas represent a distinct clinical entity?
Philip M Spanheimer1, Andrew J Stoltze, James R Howe
1Department of Surgery, University of Iowa, Iowa City, IA.
Surgery
|August 28, 2013
Summary
Giant parathyroid adenomas present uniquely with single-gland disease and fewer symptoms, despite high calcium and parathyroid hormone (PTH) levels. Post-surgery, patients face a higher risk of symptomatic hypocalcemia.
Area of Science:
- Endocrinology
- Surgical Oncology
- Biomedical Research
Background:
- Primary hyperparathyroidism (PHPT) involves variable parathyroid gland sizes.
- The clinical significance of giant parathyroid glands in PHPT remains unclear.
Purpose of the Study:
- To investigate the clinical characteristics and outcomes of patients with giant parathyroid adenomas.
- To compare patients with giant adenomas to those with non-giant adenomas.
Main Methods:
- Retrospective review of 300 patients undergoing parathyroidectomy for PHPT.
- Comparison of patients with giant adenomas (weight ≥95th percentile or 3.5g) versus others.
Main Results:
- Giant adenomas were associated with higher preoperative calcium and parathyroid hormone (PTH) levels.
- Patients with giant adenomas were less likely to have multiglandular or symptomatic disease.
- Increased incidence of symptomatic postoperative hypocalcemia observed in the giant adenoma group.
Conclusions:
- Giant parathyroid adenomas exhibit distinct clinical features, including single-gland disease and fewer symptoms.
- Resection of giant adenomas increases the likelihood of symptomatic hypocalcemia post-surgery.
Related Concept Videos
00:59The Parathyroid Glands
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...